Jazz Pharmaceuticals
Develops rare-disease medicines across sleep, epilepsy and oncology.
$244.54
After-hours close+0.06 (+0.02%)
At close$244.48(−2.64%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 128.14%Insiders 3.53%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 62.82M · Float 61.98M · 98.7% free float
Institutions13F, as of Jun 30, 2026
658 holders · 80.49M shares · 137 new positions · 379 increased · 187 reduced · 66 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.97M | 9.50% | +376.9K | Aug 7, 2026 |
| FMR LLC | 4.61M | 7.34% | +2.33M | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 3.04M | 4.83% | +53.0K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 2.73M | 4.35% | +81.3K | Aug 13, 2026 |
| Capital World Investors | 2.70M | 4.29% | +24.2K | Aug 12, 2026 |
| LSV Asset Management | 2.28M | 3.62% | −111.7K | Aug 6, 2026 |
| Franklin Resources Inc | 2.04M | 3.25% | +81.3K | Aug 13, 2026 |
| State Street Corp | 2.00M | 3.18% | +108.2K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 5.04% | 3.10M | 13G | Apr 30, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Seamus Mulligan | director | 1.29M | 2.05% | Aug 7, 2026 |
| Bruce C. Cozadd | director | 362.3K | 0.58% | Aug 7, 2026 |
| Renee D. Gala | officer: President & CEO | 147.4K | 0.23% | Jul 2, 2026 |
| Robert Iannone | officer: EVP, Global Head of R&D & CMO | 85.1K | 0.14% | Jul 2, 2026 |
| Philip L. Johnson | officer: EVP & Chief Financial Officer | 56.4K | 0.09% | Jul 2, 2026 |
| Neena M. Patil | officer: EVP & Chief Legal Officer | 48.9K | 0.08% | Jul 2, 2026 |
| Samantha Pearce | officer: EVP, Chief Commercial Officer | 47.1K | 0.08% | Aug 7, 2026 |
| Mary Elizabeth Henderson | officer: SVP, Technical Operations | 27.3K | 0.04% | Mar 9, 2026 |
| Kenneth W. O'Keefe | director | 25.8K | 0.04% | Dec 4, 2025 |
| Patrick G. Enright | director | 23.0K | 0.04% | Aug 7, 2026 |
6 ten-percent owners hold 24.48M shares by Form 4, outside the officers-and-directors figure above · 34 people have not refiled in the last 18 months (10.06M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 3, 2026 | Bruce C. Cozadddirector | Sale | 6,000 | $252.98 | 360,682 |
| Jul 1, 2026 | Bruce C. Cozadddirector | Sale | 6,000 | $240.47 | 366,682 |
| Jun 15, 2026 | Mark Douglas Smithdirector | Sale | 1,157 | $230.55 | 9,680 |
| Jun 10, 2026 | Neena M. Patilofficer: EVP & Chief Legal Officer | Sale | 1,200 | $231.83 | 51,549 |
| May 28, 2026 | Samantha Pearceofficer: EVP, Chief Commercial Officer | Sale | 6,907 | $235.41 | 50,272 |
| May 28, 2026 | Neena M. Patilofficer: EVP & Chief Legal Officer | Sale | 1,192 | $236.97 | 52,626 |
| May 22, 2026 | Heather Ann McSharrydirector | Sale | 2,000 | $241.00 | 18,449 |
| May 22, 2026 | Rick E. Winninghamdirector | Sale | 2,741 | $241.57 | 9,567 |
| May 1, 2026 | Bruce C. Cozadddirector | Sale | 6,000 | $203.33 | 378,682 |
| Apr 1, 2026 | Bruce C. Cozadddirector | Sale · 3 lots | 6,000 | $190.50 | 384,682 |
CongressHouse and Senate disclosures
Not reported.